Gene · 5214
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis. | Hematology | 2024 | 38305210 | PubTator, text mining | PubMed |
| What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine. | Can J Infect Dis Med Microbiol | 2024 | 38274122 | PubTator, text mining | PubMed |
| The m6A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35. | Cell Death Discov | 2024 | 38263362 | PubTator, text mining | PubMed |
| High-Voltage Electrostatic Field Hydrogel Microsphere 3D Culture System Improves Viability and Liver-like Properties of HepG2 Cells. | Int J Mol Sci | 2024 | 38256154 | PubTator, text mining | PubMed |
| Acetyltransferase P300 Regulates Glucose Metabolic Reprogramming through Catalyzing Succinylation in Lung Cancer. | Int J Mol Sci | 2024 | 38256128 | PubTator, text mining | PubMed |
| NAD+ Metabolism-Related Gene Profile Can Be a Relevant Source of Squamous Cell Carcinoma Biomarkers. | Cancers (Basel) | 2024 | 38254798 | PubTator, text mining | PubMed |
| Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis. | Genes Immun | 2024 | 38233508 | PubTator, text mining | PubMed |
| Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients. | Stem Cells Int | 2024 | 38229597 | PubTator, text mining | PubMed |
| PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. | Breast Cancer Res | 2024 | 38217030 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells. | Cancer Cell Int | 2024 | 38184562 | PubTator, text mining | PubMed |
| Prognostic significance and expression pattern of glucose related genes in breast cancer: A comprehensive computational biology approach. | Saudi J Biol Sci | 2024 | 38173442 | PubTator, text mining | PubMed |
| Proteomic analysis identifies PFKP lactylation in SW480 colon cancer cells. | iScience | 2024 | 38155775 | PubTator, text mining | PubMed |
| Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma. | Epigenetics | 2024 | 38154055 | PubTator, text mining | PubMed |
| Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseases. | Nat Genet | 2024 | 38049662 | PubTator, text mining | PubMed |
| PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo. | J Chemother | 2024 | 38044588 | PubTator, text mining | PubMed |
| CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma. | Adv Sci (Weinh) | 2024 | 37968249 | PubTator, text mining | PubMed |
| Indoxyl sulfate induces apoptotic cell death by inhibiting glycolysis in human astrocytes. | Kidney Res Clin Pract | 2024 | 37956994 | PubTator, text mining | PubMed |
| Hyperglycemia-induced miR182-5p drives glycolytic and angiogenic response in Proliferative Diabetic Retinopathy and RPE cells via depleting FoxO1. | Exp Eye Res | 2024 | 37952722 | PubTator, text mining | PubMed |
| Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment. | Oncogene | 2024 | 37952080 | PubTator, text mining | PubMed |
| Biomarkers Assessing the Role of Cumulus Cells on IVF Outcomes: A Systematic Review. | J Assist Reprod Genet | 2024 | 37947940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5214/papers?page=8